Autoimmune Diseases  >>  talmapimod (SCIO-469)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
talmapimod (SCIO-469) / J&J
NCT00508768: A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis

Completed
1
16
US
Oral SCIO-469 capsule
Scios, Inc.
Rheumatoid Arthritis
 
12/02

Download Options